Skip to main content


  • Sunday, Aug 24th
    4:00 PM - 4:15 PM ET
    2B-03 - Associations of the most prevalent antidepressants with mortality and cardiovascular disease: a retrospective comparative safety study in a nationwide cohort of Veterans with major depressive disorder.
    Presenting Author: Svetlana Eden, PhD – Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA
    Co-Author: Jesse Stewart, PhD – Department of Psychology, Indiana University Indianapolis, Indianapolis, IN, USA
    Co-Author: Robert Greevy, PhD – Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA
    Co-Author: Charles Alcorn, MA – University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, USA
    Co-Author: Amy Anderson-Mellies, MPH – Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
    Co-Author: Kaku So-Armah, PhD – Division of General Internal Medicine, Boston University Medical Center, Boston University Medical School, Boston, MA, USA
    Co-Author: Suman Kundu, PhD – Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
    Co-Author: Hilary Tindle, MD, MPH – Department of General Internal Medicine and Public Health, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA
    Co-Author: Matthew Freiberg, MD, MSc – 1) Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA; 2) Geriatric Research Education and Clinical Centers (GRECC), Veterans Affairs Tennessee Valley Healthcare System, Nashville, TN, USA
    Safety Outcomes / Cardiovascular
  • Sunday, Aug 24th
    4:30 PM - 4:45 PM ET
    2B-05 - The association between GLP-1 RA initiation and cardiovascular events among patients treated with levothyroxine: A target trial emulation
    Presenting Author: Fanxing Du – Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida
    Co-Author: Naykky Ospina – Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, College of Medicine, University of Florida
    Co-Author: Qing Liu – Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida
    Co-Author: Hui Shao – Hubert Department of Global Health, Rollins School of Public Health, Emory University
    Co-Author: Rozalina McCoy – Division of Endocrinology, Diabetes, and Nutrition, Department of Medicine, School of Medicine, University of Maryland
    Co-Author: Yishan Chen – Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida
    Co-Author: Juan P. Brito – Division of Endocrinology, Diabetes, Metabolism, and Nutrition, Department of Medicine, Mayo Clinic
    Co-Author: Tianze Jiao – Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida
    Safety Outcomes / Cardiovascular
  • Monday, Aug 25th
    8:15 AM - 8:30 AM ET
    3B-01 - Risk of secondary thromboembolism event following intravitreal injections of anti-VEGF agents: A target-trial emulation study
    Presenting Author: Avery Shuei-He Yang, MClinPharm – School Of Pharmacy, Institute of Clinical Pharmacy and Pharmaceutical Sciences, National Cheng Kung University
    Co-Author: Tsung-Hsien Tsai – Department of Ophthalmology, Chang Gung Memorial Hospital
    Co-Author: Lan-Hsin Chuang – Department of Ophthalmology, Chang Gung Memorial Hospital
    Co-Author: Shih-Chieh Shao, PhD. – Population Health Data Center, National Cheng Kung University, Tainan, Taiwan
    Co-Author: Edward Chia-Cheng Lai, PhD – Population Health Data Center, National Cheng Kung University
    Safety Outcomes / Cardiovascular
  • Monday, Aug 25th
    8:30 AM - 8:45 AM ET
    3B-02 - Risk of Incident Atrial Fibrillation among Female Users of Osteoporosis Treatments
    Presenting Author: Rebecca Persson, MPH – Boston Collaborative Drug Surveillance Program
    Co-Author: Tzu-Hsuan Yang, MPH – Boston Collaborative Drug Surveillance Program
    Co-Author: Zarena Jafry, MPH – Boston Collaborative Drug Surveillance Program
    Co-Author: Katrina Wilcox Hagberg, MPH – Boston Collaborative Drug Surveillance Program
    Co-Author: Catherine Vasilakis-Scaramozza, PhD – Boston Collaborative Drug Surveillance Program
    Co-Author: Susan S. Jick, DSc – Boston Collaborative Drug Surveillance Program
    Safety Outcomes / Cardiovascular
  • Monday, Aug 25th
    8:45 AM - 9:00 AM ET
    3B-03 - Risk of hemorrhage in patients on oral anticoagulants due to pharmacodynamic drug interactions: a case-crossover analysis
    Presenting Author: Ainhoa Gomez-Lumbreras, MD, PhD – Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA
    Co-Author: Dan Ouchi – Fundació Institut Universitari per a la Recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
    Co-Author: Maria Giner-Soriano, PharmD, PhD – Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
    Co-Author: Rosa Morros, MD, PhD – Fundació Institut Universitari per a la Recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
    Safety Outcomes / Cardiovascular
  • Monday, Aug 25th
    9:15 AM - 9:30 AM ET
    3F-05 - Comparative Safety of Methylphenidate and Amphetamine Initiation on Major Adverse Cardiovascular Events among Older Adults
    Presenting Author: Noah Smith, PharmD, MBA – University of Kentucky
    Co-Author: Daniel Manion – University of Kentucky
    Co-Author: Emily Slade, PhD – University of Kentucky
    Co-Author: Karen Blumenschein, PharmD, MS – University of Kentucky
    Co-Author: Chris Delcher, PhD, MS – University of Kentucky
    Co-Author: Daniela C. Moga, MD, PhD, FISPE – University of Kentucky
    Safety Outcomes / Cardiovascular
  • Tuesday, Aug 26th
    2:45 PM - 3:00 PM ET
    6G-06 - Assessing the Risk of Ventricular Arrhythmia and Sudden Death in Patients Receiving Concomitant Treatment with Antipsychotics and Selective Serotonin Reuptake Inhibitors: A Sequential Target Trial Emulation Study
    Presenting Author: Hsiu-Ting Chien – Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan
    Co-Author: Fang-Ju Lin – Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan
    Co-Author: Shu-Wen Lin – Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan
    Co-Author: Darren Toh, ScD – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA
    Safety Outcomes / Cardiovascular